News & Perspective

Feb 10, 2017

Feb 10, 2017

News Scan for Feb 10, 2017

Saudi MERS case
Senate confirms HHS pick
Avian flu update

Sep 15, 2016

Sep 15, 2016

News Scan for Sep 15, 2016

Bacillus cereus as Select Agent
Shingles vaccine in older adults
Salmonella and live poultry
Avian flu in Africa
Malaria net

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Apr 26, 2007

Apr 26, 2007

Roche cuts Tamiflu production as demand cools

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Mar 01, 2006

Mar 01, 2006

HHS orders drugs to treat 14 million in flu pandemic

(CIDRAP News) – US health officials announced today they have ordered more than 14 million treatment courses of two antiviral drugs to add to the 5.5 million courses already bought in preparation for a possible influenza pandemic.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»